InvestorsHub Logo
Followers 31
Posts 779
Boards Moderated 0
Alias Born 08/03/2020

Re: C-20 post# 136064

Friday, 12/25/2020 1:19:26 PM

Friday, December 25, 2020 1:19:26 PM

Post# of 233058
C-20

Stock price will continue to be volatile, but when Cytodyn has EUA/approval/revenues the value of the company will continue to inexorably rise.

Rising prices are what will kill the shorts.

Every share sold short must be bought back.

Shorting becomes a risky and losing proposition as price rises with the success and revenue of Cytodyn.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News